10.1038/s41467-022-28069-2 - Hyperpolarised 13C-MRI identifies the...

This document has been corrected

Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer

10.1038/s41467-022-28069-2

Published Online: 2022-01-24

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC

Authors: Amy Frary•Andrew B. Gill•Andrew N. Priest•Anne Y. Warren•Arnold J. V. Benjamin•Benjamin W. Lamb•Cara Brodie•Ferdia A. Gallagher•Fraser J. L. Robb•Ian G. Mills•Jodi L. Miller•Joshua D. Kaggie•Julia Jones•Kevin M. Brindle•Martin J. Graves•Mary A. McLean•Matthew J. Locke•Nikita Sushentsev•Nimish Shah•Rolf F. Schulte•Tristan Barrett•Vincent J. Gnanapragasam

This document has been corrected

Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer

10.1038/s41467-022-28069-2

Published Online: 2022-01-24

Journal: Nature Communications

NOW

2022-03-07•Correction

Author Correction: Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer

10.1038/s41467-022-28979-1

* information provided by CrossRef

2022-03-07•Correction

10.1038/s41467-022-28979-1

* information provided by CrossRef

2022-01-24•Published

2022-03-07•Correction

Author Correction: Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer

10.1038/s41467-022-28979-1

* information provided by CrossRef

This document has been corrected

Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer

10.1038/s41467-022-28069-2

Published Online: 2022-01-24

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC